Ni Mhuircheartaigh Orla, Crowson Cynthia S, Gabriel Sherine E, Roger Veronique L, Melton L Joseph, Amin Shreyasee
From the St. Vincent's Hospital, Dublin, Ireland; Division of Biomedical Statistics and Informatics, and Division of Epidemiology, Department of Health Sciences Research, and Division of Rheumatology, and Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota; Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
O. Ni Mhuircheartaigh, MB, BCh, BAO, BSc, MRCPI, St. Vincent's Hospital; C.S. Crowson, MS, Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, and Division of Rheumatology, Department of Medicine, Mayo Clinic; S.E. Gabriel, MD, MSc, Rutgers Robert Wood Johnson Medical School; V.L. Roger, MD, MPH, Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic and Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic; L.J. Melton III, MD, MPH, Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic; S. Amin, MD, CM, MPH, Division of Rheumatology, Department of Medicine, Mayo Clinic, and Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic.
J Rheumatol. 2017 May;44(5):558-564. doi: 10.3899/jrheum.160651. Epub 2017 Jan 15.
Women and men with rheumatoid arthritis (RA) have an increased risk for fragility fractures and cardiovascular disease (CVD), each of which has been reported to contribute to excess morbidity and mortality in these patients. Fragility fractures share similar risk factors for CVD but may occur at relatively younger ages in patients with RA. We aimed to determine whether a fragility fracture predicts the development of CVD in women and men with RA.
We studied a population-based cohort with incident RA from 1955 to 2007 and compared it with age- and sex-matched non-RA subjects. We identified fragility fractures and CVD events following the RA incidence/index date, along with relevant risk factors. We used Cox models to examine the association between fractures and the development of CVD, in which fractures and CVD risk factors were modeled as time-dependent covariates.
There were 1171 subjects (822 women; 349 men) in each of the RA and non-RA cohorts. Over followup, there were 406 and 346 fragility fractures and 286 and 225 CVD events, respectively. The overall CVD risk was increased significantly for RA subjects following a fragility fracture (HR 1.81, 95% CI 1.38-2.37) but not for non-RA subjects (HR 1.18, 95% CI 0.85-1.63). Results were similar for women and men with RA.
Fragility fractures in both women and men with RA are associated with an increased risk for CVD events and should raise an alert to clinicians to target these individuals for further screening and preventive strategies for CVD.
类风湿关节炎(RA)患者无论男女,发生脆性骨折和心血管疾病(CVD)的风险均增加,据报道,这两种情况都会导致这些患者出现额外的发病和死亡。脆性骨折与CVD有相似的危险因素,但在RA患者中可能发生在相对年轻的年龄段。我们旨在确定脆性骨折是否能预测RA患者发生CVD。
我们研究了一个基于人群的队列,该队列中的RA患者发病时间为1955年至2007年,并将其与年龄和性别匹配的非RA受试者进行比较。我们确定了RA发病/索引日期之后的脆性骨折和CVD事件,以及相关危险因素。我们使用Cox模型来研究骨折与CVD发生之间的关联,其中骨折和CVD危险因素被建模为时间依赖性协变量。
RA队列和非RA队列各有1171名受试者(822名女性;349名男性)。在随访期间,分别有406例和346例脆性骨折以及286例和225例CVD事件。脆性骨折后,RA受试者的总体CVD风险显著增加(HR 1.81,95%CI 1.38-2.37),而非RA受试者则未增加(HR 1.18,95%CI 0.85-1.63)。RA女性和男性的结果相似。
RA女性和男性的脆性骨折均与CVD事件风险增加相关,应提醒临床医生对这些个体进行进一步筛查,并采取CVD预防策略。